Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion type Assertion NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_head.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion description "[KIR-HLA pairs implicated for weak inhibition (KIR2DL2/3+HLA-C1 and KIR3DL1+HLA-Bw4(T80)) in combination with activating KIR genes associated with autoimmunity (KIR2DS2, 2DS3 and 2DS4) augment the risk of developing BCR in HLA-A*29-positive individuals.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion evidence source_evidence_literature NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion SIO_000772 18340360 NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion wasDerivedFrom befree-20140225 NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.
- NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_assertion wasGeneratedBy ECO_0000203 NP556767.RAvE3LZ6mTmtW9Vqj2Lo2kGeMJocm91iWQvB4rnynfvBk130_provenance.